000 01238 a2200337 4500
005 20250516063739.0
264 0 _c20120228
008 201202s 0 0 eng d
022 _a1744-7666
024 7 _a10.1517/14656566.2011.629187
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWang, Xiang-Yang
245 0 0 _aBlockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma.
_h[electronic resource]
260 _bExpert opinion on pharmacotherapy
_cDec 2011
300 _a2695-706 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCTLA-4 Antigen
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aIpilimumab
650 0 4 _aMelanoma
_xtherapy
650 0 4 _aSkin Neoplasms
_xtherapy
700 1 _aZuo, Daming
700 1 _aSarkar, Devanand
700 1 _aFisher, Paul B
773 0 _tExpert opinion on pharmacotherapy
_gvol. 12
_gno. 17
_gp. 2695-706
856 4 0 _uhttps://doi.org/10.1517/14656566.2011.629187
_zAvailable from publisher's website
999 _c21306297
_d21306297